Inherited disorders of renal hypomagnesaemia

Nephrology Dialysis Transplantation

Volumn 29, Issue , 2014, Pages iv63-iv71

  Konrad, Martin ^a   Schlingmann, Karl Peter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

CLDN16; Hypomagnesaemia; Magnesium; Renal genetics; TRPM6

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CALCIUM SENSING RECEPTOR; CHLORIDE CHANNEL; EPIDERMAL GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; MAGNESIUM ION; MEMBRANE PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM ION; PROTEIN CNNM2; PROTEIN FXYD2; PROTEIN KIR4.1; PROTEIN PCBD1; SODIUM CHLORIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; UNCLASSIFIED DRUG; MAGNESIUM;

AUTOSOMAL RECESSIVE DISORDER; BARTTER SYNDROME; BLOOD PH; CASR GENE; CNNM2 GENE; DISEASE ASSOCIATION; EPILEPSY ATAXIA SENSORINEURAL DEAFNESS AND RENAL SODIUM CHLORIDE WASTING WITH WITHOUT MENTAL RETARDATION; FAMILIAL HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS; FXYD2 GENE; GENE; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GITELMAN SYNDROME; HENLE LOOP; HUMAN; HYPERPHENYLALANINEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESAEMIA WITH SECONDARY HYPOCALCAEMIA; HYPOMAGNESEMIA; ISOLATED DOMINANT HYPOMAGNESAEMIA; ISOLATED RECESSIVE HYPOMAGNESEMIA; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEPLETION; MAGNESIUM METABOLISM; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; RENAL HYPOMAGNESEMIA; REVIEW; SALT WASTING; TRANSIENT NEONATAL HYPERPHENYLALANINEMIA; BLOOD; CLDN16; DISORDERS OF METAL METABOLISM; GENETICS; HYPERCALCIURIA; KIDNEY CALCIFICATION; KIDNEY TUBULE DISORDER; MAGNESIUM DEFICIENCY; RENAL GENETICS; TRPM6;

CLDN16; HYPOMAGNESAEMIA; MAGNESIUM; RENAL GENETICS; TRPM6;

HUMANS; HYPERCALCIURIA; MAGNESIUM; MAGNESIUM DEFICIENCY; METAL METABOLISM, INBORN ERRORS; NEPHROCALCINOSIS; RENAL TUBULAR TRANSPORT, INBORN ERRORS;

EID: 84911002449     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu198     Document Type: Review

References (66)

1. de Rouffignac C, Quamme G. Renal magnesium handling and its hormonal control. Physiol Rev 1994; 74: 305-322
2. Simon DB, Lu Y, Choate KA et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999; 285: 103-106
3. Konrad M, Schaller A, Seelow D et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79: 949-957
4. Hou J. Lecture: new light on the role of claudins in the kidney. Organogenesis 2012; 8: 1-9
5. Liamis G, Rodenburg EM, Hofman A et al. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 2013; 126: 256-263
6. Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001; 14: 283-290
7. Escuela MP, Guerra M, Anon JM et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Med 2005; 31: 151-156
8. Safavi M, Honarmand A. Admission hypomagnesemia - impact on mortality or morbidity in critically ill patients. Middle East J Anesthesiol 2007; 19: 645-660
9. Schlingmann KP, Konrad M. Mechanisms and disorders of magnesium metabolism. In: Alpern RJ, Moe OW, Caplan M (eds). Seldin and Giebisch's The Kidney Physiology and Pathophysiology, 5th edn. London: Academic Press, 2013, pp. 2139-2165
10. Bartter FC, Pronove P, Gill JR et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962; 33: 811-828
11. Simon DB, Bindra RS, Mansfield TA et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17: 171-178
12. Loupy A, Ramakrishnan SK, Wootla B et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012; 122: 3355-3367
13. Houillier P. Calcium-sensing in the kidney. Curr Opin Nephrol Hypertens 2013; 22: 566-571
14. Pollak MR, Brown EM, Estep HL et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 1994; 8: 303-307
15. Pearce SH,Williamson C, Kifor O et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996; 335: 1115-1122
16. Vargas-Poussou R, Huang C, Hulin P et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259-2266
17. Watanabe S, Fukumoto S, Chang H et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002; 360: 692-694
18. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221-235
19. Peters N, Bettinelli A, Spicher I et al. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome. Nephrol Dial Transplant 1995; 10: 1313-1319
20. Riveira-Munoz E, Chang Q, Godefroid N et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007; 18: 1271-1283
21. Calo L, Punzi L, Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms. Am J Nephrol 2000; 20: 347-350
22. Cruz DN, Shaer AJ, Bia MJ et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 2001; 59: 710-717
23. Simon DB, Nelson-Williams C, Bia MJ et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30
24. Vargas-Poussou R, Dahan K, Kahila D et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol 2011; 22: 693-703
25. Nijenhuis T, Vallon V, van der Kemp AW et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazideinduced hypocalciuria and hypomagnesemia. J Clin Invest 2005; 115: 1651-1658
26. Bockenhauer D, Feather S, Stanescu HC et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360: 1960-1970
27. Scholl UI, Choi M, Liu T et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 2009; 106: 5842-5847
28. Scholl UI, Dave HB, Lu M et al. SeSAME/EAST syndrome - phenotypic variability and delayed activity of the distal convoluted tubule. Pediatr Nephrol 2012; 27: 2081-2090
29. Bandulik S, Schmidt K, Bockenhauer D et al. The salt-wasting phenotype of EAST syndrome, a disease with multifaceted symptoms linked to the KCNJ10 K+ channel. Pflugers Arch 2011; 461: 423-435
30. Praga M, Vara J, González-Parra E et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995; 47: 1419-1425
31. Weber S, Schneider L, Peters M et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001; 12: 1872-1881
32. Godron A, Harambat J, Boccio V et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 2012; 7: 801-809
33. Claverie-Martin F, Garcia-Nieto V, Loris C et al. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 2013; 8: e53151
34. Ohba Y, Kitagawa H, Kitoh K et al. A deletion of the paracellin-1 gene is responsible for renal tubular dysplasia in cattle. Genomics 2000; 68: 229-236
35. Will C, Breiderhoff T, Thumfart J et al. Targeted deletion of murine Cldn16 identifies extra-and intrarenal compensatory mechanisms of Ca2+ and Mg2+ wasting. Am J Physiol Renal Physiol 2010; 298: F1152-F1161
36. Konrad M, Hou J, Weber S et al. CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2008; 19: 171-181
37. Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens 2010; 19: 483-488
38. Hou J, Renigunta A, Gomes AS et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA 2009; 106: 15350-15355
39. Schlingmann KP, Weber S, Peters M et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31: 166-170
40. Walder RY, Landau D, Meyer P et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31: 171-174
41. Schlingmann KP, Sassen MC, Weber S et al. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol 2005; 16: 3061-3069
42. Lainez S, Schlingmann KP, van der Wijst J et al. New TRPM6 missense mutations linked to hypomagnesemia with secondary hypocalcemia. Eur J Hum Genet 2014; 22: 197-504
43. Ryazanova LV, Dorovkov MV, Ansari A et al. Characterization of the protein kinase activity of TRPM7/ChaK1, a protein kinase fused to the transient receptor potential ion channel. J Biol Chem 2004; 279: 3708-3716
44. Nadler MJ, Hermosura MC, Inabe K et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 2001; 411: 590-595
45. Schmitz C, Perraud AL, Johnson CO et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 2003; 114: 191-200
46. Voets T, Nilius B, Hoefs S et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 2004; 279: 19-25
47. Chubanov V, Waldegger S, Mederos y Schnitzler M et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci USA 2004; 101: 2894-2899
48. Chubanov V, Schlingmann KP, Wäring J et al. Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative poreforming region of TRPM6. J Biol Chem 2007; 282: 7656-7667
49. Romero JR, Castonguay AJ, Barton NS et al. Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study. Transl Res 2010; 156: 235-241
50. Nair AV, Hocher B, Verkaart S et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci USA 2012; 109: 11324-9
51. Geven WB, Monnens LA, Willems HL et al. Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 1987; 31: 1140-1144
52. Meij IC, Koenderink JB, van Bokhoven H et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 2000; 26: 265-266
53. Blostein R, Pu HX, Scanzano R et al. Structure/function studies of the gamma subunit of the Na,K-ATPase. Ann N Y Acad Sci 2003; 986: 420-427
54. Cairo ER, Friedrich T, Swarts HG et al. Impaired routing of wild type FXYD2 after oligomerisation with FXYD2-G41R might explain the dominant nature of renal hypomagnesemia. Biochim Biophys Acta 2008; 1778: 398-404
55. Jones DH, Li TY, Arystarkhova E et al. Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability. J Biol Chem 2005; 280: 19003-19011
56. Glaudemans B, van der Wijst J, Scola RH et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest 2009; 119: 936-942
57. van der Wijst J, Glaudemans B, Venselaar H et al. Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia. J Biol Chem 2010; 285: 171-178
58. Stuiver M, Lainez S, Will C et al. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 2011; 88: 333-343
59. Meyer TE, Verwoert GC, Hwang SJ et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet 2010; 6: e1001045
60. Faguer S, Decramer S, Chassaing N et al. Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int 2011; 80: 768-776
61. Heidet L, Decramer S, Pawtowski A et al. Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol 2010; 5: 1079-1090
62. Adalat S, Woolf AS, Johnstone KA et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 2009; 20: 1123-1131
63. Ferre S, de Baaij JH, Ferreira Pet al.Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 2014; 25: 574-586
64. Geven WB, Monnens LA, Willems JL et al. Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet 1987; 32: 398-402
65. Groenestege WM, Thébault S, van der Wijst J et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007; 117: 2260-2267
66. Thebault S, Alexander RT, Tiel Groenestege WM et al. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009; 20: 78-85